Etorica (Micro Labs) Etoricoxib Tablets – Selective COX-2 Anti-Inflammatory Relief

### Description
Etorica is a prescription-grade nonsteroidal anti-inflammatory drug (NSAID) manufactured by Micro Labs, featuring Etoricoxib as its active pharmaceutical ingredient. As a highly selective inhibitor of the cyclooxygenase-2 (COX-2) enzyme, it effectively blocks the bodily pathways responsible for inflammation, swelling, and acute pain while minimizing the risk of severe gastric mucosal disruption typically associated with traditional non-selective NSAIDs. It is widely prescribed for managing chronic joint diseases, ankylosing spondylitis, and painful post-operative dental conditions.

### Key Features & Benefits
* Selective COX-2 Inhibition: Specifically targets inflammation pathways while sparing standard protective gastric functions.
* Sustained 24-Hour Efficacy: Formulated to provide steady, all-day joint comfort from a single daily dose.
* Trusted Pharmaceutical Quality: Manufactured to stringent safety and efficacy standards by Micro Labs.
* Rapid Pain Management: Efficiently reduces acute flare-ups, joint stiffness, and localized swelling to restore mobility.

### How to Use
1. Storage: Store at room temperature below 30°C in a dry place, away from excessive moisture, heat, and direct sunlight. Keep securely out of reach of children.
2. Preparation: Verify blister packaging integrity and choose the precise milligram strength prescribed for your therapy.
3. Administration: Take orally with a full glass of water. Can be taken with or without food, though absorption may happen faster on an empty stomach. Do not exceed the recommended dose.
4. Disposal: Safely discard any expired medication or empty blister packs according to local pharmaceutical disposal guidelines.